CBRE announced today that it has achieved the No. 1 position for medical office transactions in 2020 based on data verified by Real Capital Analytics (RCA). While RCA does not publish official rankings for the medical office sector, it verified CBRE’s market-leading position.
CBRE executed on over $1.8 billion in outpatient and inpatient investment sales in 2020, of which over $1 billion was credited by RCA to medical office transactions across 94 properties.
“Despite many challenges in 2020, our team persevered and executed for our clients when they needed us the most. Our team continues to adapt and find new ways to innovate to meet the needs of our investor clients during these unprecedented times. We are proud of our performance and are grateful to our clients for trusting us with their business,” said Chris Bodnar, Vice Chairman of CBRE Healthcare and Life Sciences Capital Markets.
CBRE’s Healthcare and Life Sciences Capital Markets concluded 2020 with over 6 million square feet in total healthcare investment sales across 26 states. The team also structured over $100 million in healthcare financings in 2020.
“It’s a great accomplishment and testament to our team’s focus on creating great outcomes for our clients. We look forward to building on this success in 2021,” said Lee Asher, Vice Chairman of CBRE Healthcare and Life Sciences Capital Markets.
